Lesinurad + XOI + Placebo + colchicine + corticosteroids
ApprovedTerminated 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Gout
Conditions
Gout, Chronic Kidney Disease (CKD)
Trial Timeline
Jul 19, 2017 → Feb 25, 2019
NCT ID
NCT03226899About Lesinurad + XOI + Placebo + colchicine + corticosteroids
Lesinurad + XOI + Placebo + colchicine + corticosteroids is a approved stage product being developed by Medpace for Gout. The current trial status is terminated. This product is registered under clinical trial identifier NCT03226899. Target conditions include Gout, Chronic Kidney Disease (CKD).
What happened to similar drugs?
11 of 20 similar drugs in Gout were approved
Approved (11) Terminated (2) Active (8)
Hype Score Breakdown
Clinical
20
Activity
0
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03226899 | Approved | Terminated |
Competing Products
20 competing products in Gout